| Orders | Qty | Bid |
|---|---|---|
| 3 | 63 | 1145.05 |
| 1 | 1 | 1145 |
| 2 | 71 | 1144.85 |
| 4 | 123 | 1144.8 |
| 3 | 90 | 1144.75 |
| Ask | Qty | Orders |
|---|---|---|
| 1145.5 | 2 | 87 |
| 1145.55 | 1 | 63 |
| 1145.6 | 3 | 74 |
| 1145.65 | 1 | 4 |
| 1145.7 | 1 | 21 |
Max Healthcare Institute Limited is one of India’s leading private hospital networks with a 25-year history of delivering tertiary and quaternary care. As on March 31, 2025, the network comprised 22 healthcare facilities with a capacity of over 5,100 beds, supported by advanced technologies and multidisciplinary clinical teams. Beyond hospitals, the Company’s ecosystem includes Max@Home (home healthcare) across 15+ cities and Max Lab (diagnostics) in 50+ cities, expanding access to care beyond traditional settings. Its clinical strengths span oncology, cardiac sciences, neurosciences, orthopaedics, renal sciences, transplants and more, with robotic surgery and modern imaging platforms deployed across the network.
Geographically, Max Healthcare serves patients across Delhi NCR (including Saket, Rajendra Place, Patparganj, Shalimar Bagh, Dwarka, Vaishali, Gurugram, Panchsheel Park, Noida and Lajpat Nagar) as well as Mumbai, Mohali, Bathinda, Dehradun, Lucknow and Nagpur. The Group had 10 subsidiaries as on March 31, 2025, including one step-down subsidiary.
External rating: CARE Ratings reaffirmed the Company’s long-term rating at CARE AA+ and short-term rating at CARE A1+.

For Q4 FY26, Max Healthcare Ins Ltd reported: Revenue (Net Sales): ₹8177.70 Cr - Up 15.03% year-on-year from ₹7109.10 Cr in Q3 FY26. Net Income (PAT): ₹2032.10 Cr - Up 8.70% year-on-year from ₹1869.50 Cr in Q3 FY26.
The intraday high for Max Healthcare Ins Ltd on the NSE today (04 Jul 2026) was ₹1,160.00. This compares to the 52-week high of ₹1,310.80 recorded on 08 Jul 2025. Today's high was -11.50% below the 52-week high.
The intraday low for Max Healthcare Ins Ltd on the NSE today was ₹1,123.50. The stock's 52-week low stands at ₹903.00, recorded on 07 Apr 2026. Today's low is 24.42% above the 52-week low, indicating the stock is trading well above its yearly lows.
As of 04 Jul 2026, the share price of Max Healthcare Ins Ltd is ₹1,153.40 on the NSE and ₹1,152.90 on the BSE. The stock opened at ₹1,145.00, touched a high of ₹1,160.00 and a low of ₹1,123.50 during today's session.
Over the last 6 months, Max Healthcare Ins Ltd has given a return of 9.80%. The stock was priced at ₹1,050.50 on 05 Jan 2026 and has Rise to ₹1,153.40 as of 04 Jul 2026, a change of ₹102.90 per share.
No,Max Healthcare Ins Ltd has not declared any dividend over the past 5 years. The company paid a total dividend of 6.00 per share between FY2022 and FY2026, with the most recent dividend of ₹2.00 per share for May 26, with an ex-dividend date of 03 Jul 2026. At the current market price of ₹1,153.40, the trailing dividend yield of Max Healthcare Ins Ltd stands at 3.50%.
Max Healthcare Ins Ltd has delivered a 308.21% absolute return over the past 5 years, equivalent to a CAGR of 32.49% per annum. The stock was priced at ₹282.55 in Jul 2021 and has risen to ₹1,153.40 as of 04 Jul 2026. An investment of ₹1,00,000 in Max Healthcare Ins Ltd five years ago would be worth ₹4,08,210.00 today.
The all-time high (ATH) for Max Healthcare Ins Ltd was ₹1,301.40, recorded on 03 Jul 2025. At the current price of ₹1,153.40, the stock is trading 11.37% below its all-time high. The all-time low recorded was ₹103.65 on 29 Oct 2020.
Max Healthcare Ins Ltd has delivered -11.15% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹1,310.80 on 08 Jul 2025 and a 52-week low of ₹903.00 on 07 Apr 2026. It is currently trading at ₹1,153.40 as of 04 Jul 2026.
Max Healthcare Ins Ltd has delivered a return of 23.81% over the last 3 months. The stock was trading at ₹944.60 on 02 Apr 2026 and is currently at ₹1,153.40 as of 04 Jul 2026, reflecting a Gain of ₹208.80 per share over this period.